- Characterization of CEA, CA 125, and CA 15-3 tumor markers, by gender and age.
| Characteristics | CEA | CA 125 | CA 15-3 |
|---|---|---|---|
| Gender | |||
| Male | 2.36±1.73 | 24.95±69.61* | 14.44±14.33 |
| Female | 2.36±29.48 | 17.73±33.90 | 14.17±12.78 |
| Age (years) | |||
| 15-30 | 1.67±0.59 | 18.23±22.19 | 12.63±5.29 |
| 31-40 | 3.08±58.20 | 18.02±17.81 | 13.38±6.29 |
| 41-50 | 1.77±1.13 | 19.29±33.66 | 14.75±23.85 |
| 51-60 | 2.29±6.59 | 16.29±48.56 | 14.43±7.99 |
| 61-70 | 2.52±2.26 | 14.24±30.31 | 15.41±9.88 |
| 71-80 | 2.90±2.46 | 17.23±45.21 | 15.38±7.35 |
| 81-90 | 3.28±2.50* | 32.00±94.54* | 17.53±10.72 |
| 91-100 | 3.10±1.36 | 25.04±39.54 | 18.08±9.25* |
Values are presented as mean ± standard deviation (SD).
↵* Elevated levels of serum tumor marker, according to gender and age groups.
CEA: carcinoembryonic antigen, CA 125: cancer antigen 125, CA 15-3: cancer antigen 15-3